1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
0 |
| Hold |
2 |
| Sell |
0 |
News Go to news feed
Conavi Medical increases revenue by 322% and significantly reduces annual loss per share
Conavi Medical reports revenue of CAD 9.12 million for the fiscal year ended 30 September 2025, up from CAD 2.16 million a year earlier, an increase of 322.22%. Loss per share narrowed to CAD -0.360 from CAD -7.080 in the prior year. The figures come from the quarterly/annual report filed on 29 December 2025. » More on finanzen.net
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 80.19K | 104.41% |
| Gross profit | -91.29K | 336.46% |
| Net profit | -3.9M | 76.03% |
| EBITDA | -3.77M | 101.14% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €9.09M |
Number of shares | 85.36M |
52-week high/low | €0.48 - €0.0867 |
| Dividends | No |
Beta | 0.55 |
P/E ratio | 13.50 |
PEG ratio | -0.02 |
P/B ratio | 19.14 |
P/S ratio | 5.24 |
Company profile
| Name | Conavi Medical Aktie |
| CEO | Thomas Looby |
| Employees | 4 |
Discover assets
Shareholders of Conavi Medical Aktie also invest in the following assets
